Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
Date:6/4/2008

SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the corporate overview on Wednesday, June 11, 2008 at 3:00 pm Eastern Time (12:00 pm Pacific Time) during the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference at the New York Palace Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue Anna Gralinska


'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
3. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
4. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
5. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
6. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
7. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
8. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
9. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
10. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
11. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... low-emission vehicles may reduce future disease b...27 (HealthDay News) -- Encouraging city dwellers t...er much greater public health benefits than increa...s have found. , The study compared the projecte... transport scenarios for London, England, and Delh...
(Date:11/27/2009)... Multi-purpose bilingual coloring books designed ... business community to educate - inform parents an...ety issues to Dinosuars to ABC,S and a host of oth... MO (PRWEB) November 27, 2009 -- Today’s chi...keep them busy any hour of the day, but one of the...
(Date:11/26/2009)... N.J., Nov. 27 The diabetes popula...the next 25 years and annual medical spending on t...om $113 billion today, according to a study publis... National Changing Diabetes ® Program (NCDP)...ysis by a team from the University of Chicago. ,...
(Date:11/26/2009)... when on an emotional rollercoaster, study finds ,... Call it the fear factor meets the jubilant sports... especially those who root for the winning team --... contested match and victory was in doubt, produci...n that this Thanksgiving weekend as you,re glued t...
(Date:11/26/2009)... Benton Communications announces a highly effecti...etailers struggling to make an economic recovery. ...09 -- Flu fears is the type of challenge that coul... according to Dr. David Benton, business growth ex...wth system – The Rfactor Intensive . &ldq...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...necologist at the Medway Maritime Hospital in Kent... is left to "twiddle his thumbs" since his hospita...o you do while you wait for the next person to tur...ents," Dr Penman said. "It's very distressing, and...
...study appearing in the journal LWT - Food Science ... can reduce the risk of Alzheimer’s disease. // ...versity led the study and have found that red cabb... The destructive action of amyloid deposits is...
...rs have proved that decrease in the fine particula... on a population. This drop in mortality rates was...respiratory disease, according to Dr. Francine Lad...d small airborne particles that are 2.5 microns in...
...f London's Imperial College said that increased ac...ld increase HIV infection rates. // Hence h...tion measures, such as patient education. Statisti...alth Organization to get anti-viral therapy to as ...
...d case of bird flu in Serbia has been reported, mu...c poultry across the Bosnian border // has been su...ne rooster and one swan near Bajina Basta, in the ...n to confirm the suspicion, said Dejan Krnjaic, He...
...mory chip or whatever fancy name you could possibl...onder woman can instantly recall dates and events,... //curiosity! She is portraying almost a perfect 1...stounding memory, that could put even a computer t...
Other Medicine News:Health News:Chip of a Woman: A 'Human Dairy', Who Has Scientists’ Eating Out Of Her Hands 2
(Date:11/25/2009)...K, Md., Nov. 25 Remediu...g cream-like foam that stops severe bleeding, won ...rity Idea category of the Global Security Challeng...lected from more than 100 entries from around the ...the GSC Security Summit conference held at the Lon...
(Date:11/25/2009)...E, N.J., Nov. 25 Regado Bioscience...t of antithrombotic aptamers with active control a...esident, will be presenting at the Piper Jaffray 2...Palace Hotel in New York City. Dr. Mazzo,s presen...ecember 1 and will include an overview of the Comp...
(Date:11/25/2009)...K, Nov. 25 Reportlinker.com announ... in its catalogue: ,, United States Dental Dev... http://www.reportlinker.com/p0158733/United-State...2015.html ,, United States Dental Devices Mark...,, This report is an essential source for in-de...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective 51180 1Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective 51180 2Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective 51180 3Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective 51180 4Perceptive Informatics Enhances CNS and Oncology Medical Image Processing and Analysis Capabilities Through Alliance With Biospective 51180 5AMN Healthcare Services to Host 2009 Second Quarter Earnings Conference Call on Thursday August 6 2009 51178 1AMN Healthcare Services to Host 2009 Second Quarter Earnings Conference Call on Thursday August 6 2009 51178 2Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 1Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 2Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 3Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 4Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 5Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 6Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial 4703 7
...ed, there is an urgent need for more,comprehensive...NEW ORLEANS, Nov. 9 A new 30-year analysis of the...(NHANES) database,conducted by the National Lipid ...re doing a better job of managing LDL or "bad" cho...ycerides, a blood fat linked to heart,disease, has...
...rom an investigational,open-label, randomized stud... (Epoetin alfa) in treating anemia in subjects wit...resented today at the American Society,of Nephrolo... including the FDA-approved,three-times-per-week (...-two-weeks (Q2W) investigational regimens, achieve...
Other Medicine Technology:New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 2New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
ULTRAMER Coude Foley Catheters (Latex) 2-Way Red
DOVER Silicone Elastomer-Coated Latex Foley Catheters 2-Way
DOVER 100% Silicone Foley Catheters 2-Way (Pediatric)
EASY-CATCH 25000 Midstream Catch Series
Medicine Products: